GB/T 42218-2022
ActiveClinical laboratory medicine—In vitro diagnostic medical devices—Validation of user quality control procedures by the manufacturer
检验医学 体外诊断医疗器械 制造商对提供给用户的质量控制程序的确认
Application Summary AI generated
This standard specifies the requirements and methodologies for manufacturers to validate the quality control procedures they provide to users of in vitro diagnostic medical devices. It is applied in the clinical laboratory medicine field, ensuring that the manufacturer-recommended QC protocols are effective for monitoring the performance of diagnostic tests and reagents in real-world laboratory settings. The standard helps guarantee the reliability and accuracy of patient test results across hospitals, clinics, and diagnostic laboratories.
Related Standards
GB/T 19634-2005
In vitro diagnostic test systems-General technical requirements for blood-glucose monitoring systems for self-testing
GB/T 47486-2026
General technical requirements for vasculature-on-a-chip
GB/Z 30154-2013
Medical laboratories―Guidance on laboratory implementation of GB/T 22576-2008
GB/Z 16886.22-2022
Biological evaluation of medical devices—Part 22:Guidance on nanomaterials
GB/Z 43281-2023
Guidance for supervisors and operators of point-of-care testing(POCT) devices
GB/Z 43280-2023
Medical laboratories—Practical guidance for the estimation of measurement uncertainty
GB/Z 44363-2024
Pyrogenicity—Principles and methods for pyrogen testing of medical devices
GB/Z 157-2026
In vitro diagnostic test systems—Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.